Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
6.765 USD | +0.37% | +3.28% | +49.67% |
04-02 | ADMA Biologics, Inc. Announces Promotion of Kaitlin Kestenberg as Chief Operating Officer | CI |
03-26 | HC Wainwright Adjusts ADMA Biologics Price Target to $7.50 From $6, Maintains Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+49.67% | 1.56B | |
-3.79% | 87.06B | |
+1.45% | 40.25B | |
-16.09% | 31.09B | |
+52.66% | 24.74B | |
-14.32% | 15.91B | |
-9.12% | 11.96B | |
-15.03% | 11.92B | |
-42.56% | 11.61B | |
+4.87% | 8.73B |
- Stock Market
- Equities
- ADMA Stock
- News ADMA Biologics, Inc.
- ADMA Biologics Says FDA Approves Supplemental BLAs for Room Temperature Storage of ASCENIV and BIVIGAM